Revolution Healthcare Acquisition Corp. (REVHU) Prices $500M IPO

Revolution Healthcare Acquisition Corp. announced the pricing of its $500 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “REVHU,” Thursday, March 18.

The new company aims to combine with a patient-centric healthcare target that uses technology in innovative ways to improve outcomes. Revolution Healthcare is led by CEO Jay Markowitz, MD, CFO Mark McDonnell, Chief Administrative Officer Jason Doren, COO Evan Sotiriou, and Chairman Jeff Leiden, MD, PhD.

Total SPAC deal count for 2021 year-to-date is now 268. This offering is expected to close on Monday, March 22.

Morgan Stanley & Co. LLC is serving as the lead book-running manager, and Loop Capital Markets is acting as co-manager for this offering. Goodwin Procter LLP is serving as Issuer’s Counsel with Kirkland & Ellis LLP serving as Underwriter’s Counsel. WithumSmith+Brown, PC serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.